Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor [NA]

View source ↗

Summary

Clinical trial update indicating that the staged bilateral Exablate treatment for medication-refractory essential tremor has completed, sponsored by InSightec.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: InSightec | Conditions: Essential Tremor | NA | Status: COMPLETED